Assessing the replicability of RCTs in RWE emulations
Abstract Background The standard regulatory approach to assess replication success is the two-trials rule, requiring both the original and the replication study to be significant with effect estimates in the same direction. The sceptical p-value was recently presented as an alternative method for th...
Saved in:
| Main Authors: | Jeanette Köppe, Charlotte Micheloud, Stella Erdmann, Rachel Heyard, Leonhard Held |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | BMC Medical Research Methodology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12874-025-02589-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
After Zigzagging Between Extremes, Finally Common Sense? Will Belgium Return to Reasonable Rules on Illegally Obtained Evidence?
by: Frank Verbruggen, et al.
Published: (2021-03-01) -
DNA repair and replicative stress addiction in neuroblastoma
by: Kaat Durinck, et al.
Published: (2024-12-01) -
Role of RWD / RWE in health technology assessment
by: V. G. Borovskaya, et al.
Published: (2023-03-01) -
Landscape of informed consent practices and challenges in point‐of‐care clinical trials
by: Caleigh Propes, et al.
Published: (2025-07-01) -
Erratum: Real-world evidence (RWE): a challenge for regulatory agencies discussion of the RWE conference with the network of the European medicine agencies, patients, and experts
by: Frontiers Production Office
Published: (2025-04-01)